| 摘要 |
<p>The invention concerns an aqueous solution based on 1-[2-(2-naphthyl)ethyl]-4-3(3-trifluoromethylphenyl) -1,2,3,6-tetrahydropyridine chlorhydrate (SR 57746 chlorhydrate), also comprising β-cyclodextrin (β-CD) and a pharmaceutically acceptable acid or buffer to ensure a pH not more than 3.</p> |
